Variable

No of patients

Univariate P

Multivariate P

HR

95% CI

Age

<70

≥70

n = 17

n = 21

0.45

Gender

M

F

n = 17

n = 21

0.39

WBC (/μl)

<6500

≥6500

n = 13

n = 25

0.72

Neutrophil (/μl)

<5000

≥5000

n = 17

n = 21

0.36

Lymphcyte (/μl)

<1200

≥1200

n = 15

n = 23

0.82

NLR

<5

≥5

n = 25

n = 13

0.01

0.03

2.8

1.1 - 6.6

AST (IU/l)

<20

≥20

n = 8

n = 30

0.31

ALT (IU/l)

<30

≥30

n = 28

n = 10

<0.01

<0.01

5.0

1.9 - 13.1

T.Bil (mg/dl)

<0.8

≥0.8

n = 29

n = 9

0.88

T.P (g/dl)

<6.0

≥6.0

n = 5

n = 33

0.66

Alb (g/dl)

<3.5

≥3.5

n = 15

n = 23

0.72

CEA (ng/ml)

<5.0

≥5.0

n = 3

n = 35

0.06

CA19-9 (U/ml)

<60

≥60

n = 11

n = 27

0.94

CRP (mg/dl)

<1

≥1

n = 18

n = 20

0.52

GPS

<1

≥1

n = 14

n = 24

0.73

Tumor location

Colon

Rectum

n = 34

n = 4

0.31

Pathology

Diff

Non Diff

n = 32

n = 6

0.19

Serosal invasion

Yes

No

n = 28

n = 10

0.95

Vascular invasion

Yes

No

n = 32

n = 6

0.38

Lymphatic invasion

Yes

No

n = 27

n = 11

0.64

Lymph-node metastasis

Yes

No

n = 28

n = 10

0.48

Hepatic metastasis

Yes

No

n = 4

n = 34

0.59

Lung metastasis

Yes

No

n = 13

n = 25

0.21

Peritoneal metastasis

Yes

No

n = 6

n = 32

0.24

Chemotherapy

Yes

No

n = 26

n = 12

0.01

<0.01

3.5

1.5 - 8.1